The price-to-earnings ratio for Resmed Inc. (NYSE: RMD) is above average at 34.68x, Company’s 36-month beta value is 0.68.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 3 as “sell.”
The public float for RMD is 145.75M, and currently, short sellers hold a 6.71% ratio of that floaft. The average trading volume of RMD on August 27, 2024 was 1.08M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RMD) stock’s latest price update
Resmed Inc. (NYSE: RMD)’s stock price has increased by 6.29 compared to its previous closing price of 225.86. However, the company has seen a 7.58% increase in its stock price over the last five trading sessions. globenewswire.com reported 2024-08-15 that SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced it has expanded the size of its board of directors to 11 and has elected Christopher DelOrefice to the board, effective immediately. Mr. DelOrefice was appointed during ResMed’s regularly scheduled board meeting on August 15, 2024, and will stand for re-election with the rest of ResMed’s directors at its annual meeting on November 21, 2024. Mr. DelOrefice has also been appointed as a member of ResMed’s board audit committee.
RMD’s Market Performance
Resmed Inc. (RMD) has seen a 7.58% rise in stock performance for the week, with a 15.11% gain in the past month and a 15.87% surge in the past quarter. The volatility ratio for the week is 2.14%, and the volatility levels for the past 30 days are at 3.15% for RMD. The simple moving average for the last 20 days is 9.05% for RMD stock, with a simple moving average of 25.85% for the last 200 days.
Analysts’ Opinion of RMD
KeyBanc Capital Markets gave a rating of “Overweight” to RMD, setting the target price at $227 in the report published on February 06th of the current year.
RMD Trading at 15.48% from the 50-Day Moving Average
After a stumble in the market that brought RMD to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 3.70% of gains for the given period.
Volatility was left at 3.15%, however, over the last 30 days, the volatility rate increased by 2.14%, as shares surge +15.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.28% upper at present.
During the last 5 trading sessions, RMD rose by +7.48%, which changed the moving average for the period of 200-days by +61.21% in comparison to the 20-day moving average, which settled at $221.71. In addition, Resmed Inc. saw 39.55% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RMD starting from Rider Michael J, who sale 882 shares at the price of $231.00 back on Aug 20 ’24. After this action, Rider Michael J now owns 10,512 shares of Resmed Inc., valued at $203,742 using the latest closing price.
Rider Michael J, the Officer of Resmed Inc., proposed sale 883 shares at $230.74 during a trade that took place back on Aug 20 ’24, which means that Rider Michael J is holding shares at $203,742 based on the most recent closing price.
Stock Fundamentals for RMD
Current profitability levels for the company are sitting at:
- 0.29 for the present operating margin
- 0.58 for the gross margin
The net margin for Resmed Inc. stands at 0.22. The total capital return value is set at 0.22. Equity return is now at value 22.70, with 14.99 for asset returns.
Based on Resmed Inc. (RMD), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at 1.91. The debt to equity ratio resting at 0.15. The interest coverage ratio of the stock is -28.88.
Currently, EBITDA for the company is 1.6 billion with net debt to EBITDA at 0.39. When we switch over and look at the enterprise to sales, we see a ratio of 7.89. The receivables turnover for the company is 5.19for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.59.
Conclusion
In a nutshell, Resmed Inc. (RMD) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
